Science Explorer Interactive view Map
Topic · Public Health, Environmental and Occupational Health

Acute Lymphoblastic Leukemia research

Acute Lymphoblastic Leukemia research is a research topic within Public Health, Environmental and Occupational Health. Science Explorer counts 40k research works in it since 1950. 19.4% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the epidemiology, genetic basis, treatment, and outcomes of childhood acute lymphoblastic leukemia (ALL). It covers topics such as genetic alterations, minimal residual disease, pharmacogenomics, prognostic factors, and relapse risk. The papers also discuss the challenges and advancements in pediatric oncology for the treatment of childhood leukemia.

  • Childhood Cancer
  • Acute Lymphoblastic Leukemia
  • Genetic Alterations
  • Treatment Outcome
  • Minimal Residual Disease
  • Pharmacogenomics
  • Prognostic Factors
  • Thiopurine Therapy
  • Relapse Risk
  • Pediatric Oncology
Research works
40k
fractional, since 1950
In the world top 10%
7.8k
per year above
Top-10% rate
19.4%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+17%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Acute Lymphoblastic Leukemia research research?

By volume, the United States and China publish the most (2k and 852 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 2k works
  2. 2 China 852 works
  3. 3 India 407 works
  4. 4 Brazil 358 works
  5. 5 Germany 240 works
  6. 6 Japan 232 works
  7. 7 Italy 222 works
  8. 8 United Kingdom 212 works
  9. 9 France 199 works
  10. 10 Canada 165 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 40.8%China: 17.5%India: 8.3%Brazil: 7.3%6 others listed: 26.1%41%largest
United States1,992 · 40.8%China852 · 17.5%India407 · 8.3%Brazil358 · 7.3%6 others listed1,272 · 26.1%

Shares of the rows listed above, not of the whole node.

Which institutions lead Acute Lymphoblastic Leukemia research research?

By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Acute Lymphoblastic Leukemia research research, followed by St. Jude Children's Research Hospital and Chinese Academy of Medical Sciences & Peking Union Medical College.

By volume, 2022–2025

  1. 1 The University of Texas MD Anderson Cancer CenterUnited States 124 works
  2. 2 St. Jude Children's Research HospitalUnited States 63 works
  3. 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 31 works
  4. 4 Dana-Farber Cancer InstituteUnited States 30 works
  5. 5 Moffitt Cancer CenterUnited States 26 works
  6. 6 All India Institute of Medical SciencesIndia 26 works
  7. 7 Institute of Hematology & Blood Diseases HospitalChina 25 works
  8. 8 Baylor College of MedicineUnited States 25 works
  9. 9 City of HopeUnited States 25 works
  10. 10 Memorial Sloan Kettering Cancer CenterUnited States 24 works

Who are the leading researchers in Acute Lymphoblastic Leukemia research?

The most-cited researchers publishing on Acute Lymphoblastic Leukemia research include Kenneth J. Livak, Gad Getz and Elisabete Weiderpass.

  1. 1 Kenneth J. Livak United States 20k citations
  2. 2 Gad Getz United States 6.2k citations
  3. 3 Elisabete Weiderpass France 6k citations
  4. 4 Hagop M. Kantarjian United States 4k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Acute Lymphoblastic Leukemia research research done?

The largest centres of Acute Lymphoblastic Leukemia research research in 2022–2025 are Houston (United States), Beijing (China), São Paulo (Brazil) and New York (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Lancaster, Memphis and Houston.

Largest cities, 2022–2025

  1. 1 Houston United States 171 works
  2. 2 Beijing China 160 works
  3. 3 São Paulo Brazil 96 works
  4. 4 New York United States 86 works
  5. 5 Paris France 84 works
  6. 6 Moscow Russia 80 works
  7. 7 Guangzhou China 79 works
  8. 8 London United Kingdom 77 works
  9. 9 Boston United States 77 works
  10. 10 Memphis United States 73 works

Where it is the local speciality

  1. LancasterUS · 24.6 works46×
  2. MemphisUS · 72.7 works22×
  3. HoustonUS · 171.1 works10×
  4. TampaUS · 40.7 works8.6×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Acute Lymphoblastic Leukemia research than the world average.

See Acute Lymphoblastic Leukemia research on the map

Where is the best place to study Acute Lymphoblastic Leukemia research?

Among universities, judged by research, Medical University of Lublin, Baylor College of Medicine and Karolinska Institutet score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 21.27%fractional works in this node (log) →share in the world top 10% →Medical University of Lublin: 13, 24.3%Baylor College of Medicine: 24, 17.0%Karolinska Institutet: 11, 25.6%Medizinische Hochschule Hannover: 10, 23.4%Post Graduate Institute of Medical Education and Research: 18, 11.4%University of Alabama at Birmingham: 14, 21.2%Medical College of Wisconsin: 13, 16.2%Harvard University: 18, 26.7%University of Pennsylvania: 23, 21.4%University of Washington: 21, 25.5%Karolinska InstitutetMedical University o…Medizinische Hochsch…Baylor College of Me…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Medical University of LublinPoland 57.224.3%11.8×13 -6.3%
2 Baylor College of MedicineUnited States 56.017.0%9.2×24 +45.6%
3 Karolinska InstitutetSweden 53.025.6%3.7×11 +50.2%
4 Medizinische Hochschule HannoverGermany 49.023.4%7.0×10 +2.0%
5 Post Graduate Institute of Medical Education and ResearchIndia 48.611.4%8.3×18 +126.1%
6 University of Alabama at BirminghamUnited States 48.021.2%4.2×14 +140.4%
7 Medical College of WisconsinUnited States 47.116.2%7.7×13 +72.0%
8 Harvard UniversityUnited States 46.626.7%2.0×18 +9.3%
9 University of PennsylvaniaUnited States 45.321.4%3.7×23 +30.5%
10 University of WashingtonUnited States 45.325.5%3.0×21 -8.5%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Acute Lymphoblastic Leukemia research research growing?

Output in 2018–2022 was 17% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Acute Lymphoblastic Leukemia research.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.